Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

2.73
Delayed Data
As of 3:59pm ET
 -0.002 / -0.07%
Today’s Change
1.51
Today|||52-Week Range
9.50
+31.15%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close2.73
Today’s open2.77
Day’s range2.71 - 2.80
Volume59,175
Average volume (3 months)220,950
Market cap$18.4M
Dividend yield--
Data as of 3:59pm ET, 08/27/2015

Growth & Valuation

Earnings growth (last year)+18.03%
Earnings growth (this year)--
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book15.20

Competitors

 Today’s
change
Today’s
% change
CYCCCyclacel Pharmaceuti...+0.01+1.98%
OPXAOpexa Therapeutics I...+0.04+13.17%
DARADARA BioSciences Inc-0.00-0.14%
ECTEEcho Therapeutics In...-0.03-1.97%
Data as of 3:59pm ET, 08/27/2015

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$6.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Iain Gladstone Ross
COO, Head-Administration &
Finance
Cristyn Humphreys
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts

Partner Offers